Medical News on Cancer
Nanoparticles Shrink Ovarian Cancer Tumors In Mice
Aug 17, 2012
By sequencing cancer-cell genomes, researchers have found a substantial amount of genes that happen to be mutated, deleted or duplicated within cancerous cells. This treasure chest is a great asset for scientists searching for innovative drug targets, however, it's extremely difficult to examine all of them promptly... Read More
Particles That Shut Off Cancer Genes Could Also Allow Researchers To Screen Potential Drug Targets More Rapidly
Aug 17, 2012
By sequencing cancer-cell genomes, scientists have discovered vast numbers of genes that are mutated, deleted or copied in cancer cells. This treasure trove is a boon for researchers seeking new drug targets, but it is nearly impossible to test them all in a timely fashion... Read More
Skin Cancer: Potential New Treatment Target Identified For Melanoma
Aug 17, 2012
New research from Western University, Canada, has identified a potential new target for the treatment of melanoma, the deadliest of all skin cancers. Silvia Penuela and Dale Laird discovered a new channel-forming protein called Pannexin (Panx1) that is expressed in normal levels on the surface of healthy skin cells. But they found, in melanoma, Panx1 is over-produced to a pathological level... Read More
By Studying Animal Health, Researchers Find Improved Ways For Developing, Testing Cancer Therapies
Aug 17, 2012
A group of Kansas State University researchers has made valuable findings in the search for cancer's cure. While researching ways to improve animal health, the scientists -- Raymond "Bob" Rowland, a virologist and professor of diagnostic medicine and pathobiology, and Deryl Troyer, professor of anatomy and physiology -- have made two important discoveries that can also improve human health... Read More
Combining BRAF Inhibitor And Immunotherapy Increases Antitumor Activity In Metastatic Melanoma
Aug 17, 2012
BRAF Inhibitor Zelboraf Boosts Effectiveness of Immunotherapy in Mouse ModelCombining the recently approved BRAF inhibitor, Zelboraf with an engineered T cell immunotherapy to treat metastatic melanoma significantly increased tumor responses and survival in an animal model, researchers at UCLA's Jonsson Comprehensive Cancer Center have shown... Read More
China's Increasing Cancer Rates Linked To Industrialization, New Lifestyles And Lack Of Sun Exposure
Aug 16, 2012
Avoiding direct exposure to sunlight is generally seen as a good way of reducing skin cancer risk. However, Chinese scientists demonstrated that death rates in China (as in the West) from several major cancer are lower among people with more ambient UVB radiation. The same is true for some other cancers, including those of the cervix, rectum, colon, stomach and esophagus... Read More
Cause Of Chemotherapy Resistance In Ovarian Cancer Identified
Aug 16, 2012
According to a study published in the journal Cancer Research, researchers have found a possible cause as to why the most prevalent type of ovarian cancer often becomes resistant to chemotherapy. In the UK, more than 4,000 women die each year from ovarian cancer, with 65% of these deaths caused by High Grade Serous Cancer (HGSC) - the most common type of ovarian cancer... Read More
Home Testing Kits Increase Colorectal Cancer Screening Rates
Aug 16, 2012
Screening for colorectal cancer (CRC) is cost-effective and saves lives by early detection. The ability to screen large numbers of individuals is especially important for states with tight health insurance budgets dealing with aging populations. However, in 2010 only 65 percent of U.S. adults between ages 50 and 75 got the recommended screening... Read More
Novel Drug Combination Offers New Strategy To Destroy Multiple Myeloma
Aug 16, 2012
Researchers at Virginia Commonwealth University Massey Cancer Center are reporting promising results from laboratory and animal experiments involving a new combination therapy for multiple myeloma, the second most common form of blood cancer... Read More
Cause Of Burkitt Lymphoma Discovered
Aug 15, 2012
Burkitt lymphoma is an extremely fast growing form of non-Hodgkin's lymphoma that originates from a subgroup of white blood cells called B lymphocytes of the immune system. Now, researchers at the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch have discovered a vital component that converts the immune cells into malignant lymphoma cells. According to Dr... Read More
Previous Page Next Page